Navigation Links
Nanotrope, Inc. Receives Patent on New Diagnostic Test for Influenza and Other Viral Infections
Date:11/17/2010

SAN DIEGO, Nov. 17, 2010 /PRNewswire/ -- Nanotrope, Inc. announced today that it has been issued United States patent #7,829,272 covering its ground-breaking diagnostic test for influenza and other viral infections. The patent describes Nanotrope's cellular mimic technology that creates an artificial "cell" engineered with specific membrane compositions and surface receptors which stimulate the virus into infecting the mimic as it would a normal host cell.  Once the cell mimic is infected, viral genome sequences are detected by multi-color fluorescence providing both viral typing and sub-typing capabilities. The sensitivity of the test is comparable to PCR (polymerase chain reaction) detection limits but in a faster, less expensive and simpler format.

The Nanotrope assay may be used to identify any envelope virus, a class of viruses that includes such important infectious disease targets as influenza where the assay can distinguish between seasonal, swine, and pandemic flu strains, RSV, a serious lung disease in young children, West Nile virus, SARS, measles, and rabies. For contagious viral infections, it is important to identify the virus early in the course of the infection so that sick patients may be isolated and properly treated. The high sensitivity, short time to result, and sub-typing capability of the new assay makes it well-suited for hospital and clinical labs where the time to diagnosis is important, as well as for global surveillance for vaccine development.

Nanotrope is a privately held nano-biomaterials company with a focus on developing new products for the pharmaceutical and diagnostic industries. Its expertise in particle technology has enabled a diverse portfolio of intellectual property. The company is actively looking for partners to commercialize its diagnostics technology. Inquiries may be directed to Dr. Donald Ackley at 858-847-7300, don@nanotrope.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Dr. Donald E Ackley

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=99308


'/>"/>
SOURCE Nanotrope, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software
2. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
3. SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms
4. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
5. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
6. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
7. Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents
8. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
9. Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
10. TorreyPines Therapeutics Receives NASDAQ Deficiency Notice
11. Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. ... STACS DNA as a Field Application Specialist. , “I am thrilled that Dr. ... STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings a ...
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the ... Convention Center and will showcase its product’s latest features from June 26 to ... a scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... June 22, 2016  Amgen (NASDAQ: AMGN ... QB3@953 life sciences incubator to accelerate the ... shared laboratory space at QB3@953 was created to help ... obstacle for many early stage organizations - access to ... sponsorship, Amgen launched two "Amgen Golden Ticket" awards, providing ...
Breaking Biology Technology:
(Date:6/9/2016)... , June 9, 2016 ... deploy Teleste,s video security solution to ensure the safety of ... during the major tournament Teleste, an ... systems and services, announced today that its video security solution ... to back up public safety across the country. The ...
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:6/2/2016)... 2, 2016   The Weather Company , an IBM ... an industry-first capability in which consumers will be able to ... ask questions via voice or text and receive relevant information ... Marketers have long sought an advertising solution that ... be personal, relevant and valuable; and can scale across millions ...
Breaking Biology News(10 mins):